Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial

Objectives Some patients with rheumatoid arthritis develop interstitial lung disease (RA-ILD) that develops into progressive pulmonary fibrosis. We assessed the efficacy and safety of nintedanib versus placebo in patients with progressive RA-ILD in the INBUILD trial. Methods The INBUILD trial enroll...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical rheumatology 2023-09, Vol.42 (9), p.2311-2319
Hauptverfasser:	Matteson, Eric L., Aringer, Martin, Burmester, Gerd R., Mueller, Heiko, Moros, Lizette, Kolb, Martin
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse events Bronchiectasis Computed tomography decline Diarrhea Diarrhea - chemically induced Disease Progression drugs Fibrosis glucocorticoids Humans Lung diseases Lung Diseases, Interstitial - complications Medicine Medicine & Public Health Original Original Article Placebos Protein Kinase Inhibitors - adverse effects Pulmonary fibrosis Pulmonary Fibrosis - complications Rheumatoid arthritis Rheumatology Safety tomography Vital Capacity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!